{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:17:12Z","timestamp":1758266232298},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T00:00:00Z","timestamp":1550707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"MRC Newton Fund","award":["MR\/MO2654X4\/1"],"award-info":[{"award-number":["MR\/MO2654X4\/1"]}]}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ijid.2019.02.026","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T12:14:40Z","timestamp":1551096880000},"page":"S17-S19","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S","title":["BCG vaccination following latent TB treatment: Possible implications for different settings"],"prefix":"10.1016","volume":"80","author":[{"given":"L.","family":"Gosc\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bitencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.C.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"August (33)","key":"10.1016\/j.ijid.2019.02.026_bib0005","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"Abu-Raddad","year":"2009","journal-title":"Proc Natl Acad Sci"},{"issue":"September (37)","key":"10.1016\/j.ijid.2019.02.026_bib0010","first-page":"1","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette\u2013Gu\u00e9rin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess (Winchester, England)"},{"issue":"October (1)","key":"10.1016\/j.ijid.2019.02.026_bib0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s12879-015-1201-8","article-title":"Effect of isoniazid preventive therapy on immune responses to Mycobacterium tuberculosis: an open label randomised, controlled, exploratory study","volume":"15","author":"Biraro","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"December (1)","key":"10.1016\/j.ijid.2019.02.026_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12879-015-0764-8","article-title":"Active and latent tuberculosis in Brazilian correctional facilities: a cross-sectional study","volume":"15","author":"Carbone","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.ijid.2019.02.026_bib0025","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"issue":"April (14)","key":"10.1016\/j.ijid.2019.02.026_bib0030","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1073\/pnas.1317660111","article-title":"Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings","volume":"111","author":"Houben","year":"2014","journal-title":"Proc Natl Acad Sci"},{"issue":"July (7)","key":"10.1016\/j.ijid.2019.02.026_bib0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1473-3099(10)70078-5","article-title":"Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources","volume":"10","author":"Lawn","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2019.02.026_bib0040","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"December (18)","key":"10.1016\/j.ijid.2019.02.026_bib0045","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","article-title":"Twice weekly tuberculosis preventive therapy in HIV infection in Zambia","volume":"12","author":"Mwinga","year":"1998","journal-title":"AIDS"},{"issue":"July (2)","key":"10.1016\/j.ijid.2019.02.026_bib0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis infection with H4: IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med"},{"issue":"August","key":"10.1016\/j.ijid.2019.02.026_bib0055","doi-asserted-by":"crossref","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"issue":"March (3)","key":"10.1016\/j.ijid.2019.02.026_bib0060","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3201\/eid2103.140896","article-title":"Prisons as reservoir for community transmission of tuberculosis, Brazil","volume":"21","author":"Sacchi","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"September (6)","key":"10.1016\/j.ijid.2019.02.026_bib0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7326\/M14-1019","article-title":"Treatment of latent tuberculosis infection: a network meta-analysis","volume":"161","author":"Stagg","year":"2014","journal-title":"Ann Intern Med"},{"issue":"July","key":"10.1016\/j.ijid.2019.02.026_bib0070","first-page":"1501996","article-title":"Bacillus Calmette\u2013Guerin (BCG) revaccination of adults with latent Mycobacterium tuberculosis infection induces long-lived BCG-reactive NK cell responses","author":"Suliman","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2019.02.026_bib0075","series-title":"Infection: updated and consolidated guidelines for programmatic management","author":"World Health Organization (WHO)","year":"2018"},{"issue":"February (4)","key":"10.1016\/j.ijid.2019.02.026_bib0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/aje\/153.4.381","article-title":"Early therapy for latent tuberculosis infection","volume":"153","author":"Ziv","year":"2001","journal-title":"Am J Epidemiol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219300906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219300906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T17:12:45Z","timestamp":1552065165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219300906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":16,"alternative-id":["S1201971219300906"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.02.026","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCG vaccination following latent TB treatment: Possible implications for different settings","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}